BioMarin to Host R&D Day in New York City

Date Posted:
Apr 19, 2016

San Rafael-based BioMarin Pharmaceutical will host an R&D day on Wednesday April 20th, with BioMarin management and external experts providing an update to the investment community on the Company’s development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases.

In addition to BioMarin CEO Jean-Jacques Bienaimé and other C-level executives, Cary Harding, M.D., Professor of Molecular and Medical Genetics and Pediatrics at Oregon Health and Science University, John Pasi, Ph.D., Professor of Haemostasis and Thrombosis, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, and Ravi Savarirayan, M.D., Professor, Department of Paediatrics, University of Melbourne will report on work within BioMarin’s development pipeline.

For more information on the event, including live webcast and audio options, visit the BioMarin website.